
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | 400-500 |
| Total Number of Projects: | > 1000 |
| 2012 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2009 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 1
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 1*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 14.999.335 | 404.375 | 1 | ||
| 2018 | 2.986.699 | 0 | 2.986.699 | 1 | ||
| 2013 | 1.043.000 | 0 | 426.160 | 1 | ||
Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-02-01 | Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer | DECIDER | participant | 14.999.335 | 14 |
| 2018-02-01 | Micro-tumor Guided Cancer Therapy Selection MicroCaT | MicroCaT | coordinator | 2.986.699 | 1 |
| 2013-04-01 | Chemotherapy guidance based on efficacy of treatment regimen in cancer cells from the individual patient | CHEMOGUIDE | coordinator | 1.043.000 | 5 |